Jack W. Schuler - May 5, 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role: 10%+ Owner
Signature: /s/ Jack W. Schuler
Stock symbol: YTEN
Transactions as of: May 5, 2023
Transactions value $: $1,999,997
Form type: 4
Date filed: 5/9/2023, 08:11 AM
Previous filing: Feb 1, 2023
Next filing: May 24, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	YTEN	Common Stock	Purchase	$1M	+336K	+53.49%	$2.98	963K	May 5, 2023	By Jack W. Schuler Living Trust	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	YTEN	Common Stock Warrants	Purchase	$1M	+336K		$2.98	336K	May 5, 2023	Common Stock	336K	$2.98	By Jack W. Schuler Living Trust	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities comprise 335,570 shares of Common Stock purchased from the Issuer by the Jack W. Schuler Living Trust on May 5, 2023 for $2.98 per share, pursuant to a Securities Purchase Agreement, dated May 3, 2023 (the "Purchase Agreement"), by and among the Issuer and certain investors named therein (the "Investors").
F2	Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock and Warrants held by the Living Trust.
F3	In a concurrent private placement effected pursuant to the Purchase Agreement, on May 5, 2023 the Issuer issued to the Investors Warrants to purchase one share of Common Stock at an exercise price of $2.98 per share for each share of Common Stock purchased pursuant to the Purchase Agreement. The reported securities comprise 335,570 Warrants so issued to the Jack W. Schuler Living Trust. The Warrants will be exercisable beginning six months from the date of issuance and will terminate five years from such initial exercisability date.